help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, J. A.
Right arrow Articles by Culbreth, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, J. A., Jr
Right arrow Articles by Culbreth, R. R.

Am. J. Respir. Cell Mol. Biol., Vol 15, No. 2, 08 1996, 207-215.

Characterization of a neutrophil inhibitor peptide harvested from human bronchial lavage: homology to influenza A nucleoprotein

JA Cooper Jr and RR Culbreth
Pulmonary Section, Birmingham Veterans Administration Medical Center (VAMC), Alabama, USA.

Bronchi are exposed to particulate matter, including bacteria, fungi and dusts, that should trigger release of molecules which attract polymorphonuclear neutrophils (PMN). However, normal bronchi are relatively devoid of PMN, suggesting that there exists a mechanism to dampen acute inflammation in the lung. We have previously reported that bronchial lavage from normal humans contains a nonpolar peptide that inhibits PMN chemotaxis and oxidant production. In the present study we devised preparative methods to obtain sufficient quantities of a similar inhibitor molecule for partial amino acid sequencing and allow production of truncated analogues. Amino acid sequencing demonstrated that the peptide includes a 10-amino-acid sequence that is completely homologous to a sequence of amino acids contained in the influenza A nucleoprotein. Synthesized peptides containing this 10-amino-acid sequence inhibited PMN chemotaxis and oxidant production. In addition, PMN lysates actively phosphorylated peptides containing the 10-amino- acid sequence or a partial sequence containing an apparent phosphorylation site. U937 cells were noted to be one source of this inhibitor, as a similarly sized nonpolar inhibitor peptide was purified from U937 culture supernatants. In addition, U937 and monocyte cellular lysates contained proteins recognized by an antiserum directed at the influenza A nucleoprotein. Further characterization of the molecule described in this study or related molecules may lead to significantly new antiinflammatory strategies.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Y. Reynolds
Lung Inflammation and Fibrosis: An Alveolar Macrophage-centered Perspective from the 1970s to 1980s
Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 98 - 102.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. A. D. COOPER Jr., A. L. RIDGEWAY, J. PEARSON, and R. R. CULBRETH
Attenuation of Interleukin 8-induced Nasal Inflammation by an Inhibitor Peptide
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1198 - 1205.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1996 American Thoracic Society.